Rheumatoid Arthritis Test

Rheumatoid Arthritis is a serious autoimmune condition that causes your own autoimmune system to mistakenly attack itself.

Rheumatoid Arthritis starts to develop months before symptoms show, and causes joint pain, arthritis and often permanent joint damage.

Over 2 Million Americans are estimated to have RA, and about 1.3 Million Americans were diagnosed with RA as of 2014.

Rheumatoid Arthritis starts to develop months before symptoms show, so early testing can significantly reduce time to diagnosis.

Early treatment is critical to slowing the progression of RA, preventing long-term joint damage, and protecting your overall health.

If left untreated, over 20% of patients become severely debilitated within the first 3 years following initial diagnosis.

Over 2 Million Americans are estimated to have RA, and about 1.3 Million Americans were diagnosed with RA as of 2014.

You may have rheumatoid arthritis if a family member of yours has been also been diagnosed.

First-degree family members are 5 times more likely to have rheumatoid arthritis as well.

imaware™ is the only at-home rheumatoid arthritis screening test capable of detecting the cyclic citrullinated peptide antibody (CCP-IgG).

CCP-IgG is a unique biomarker that can provide awareness of RA before symptoms appear.

We also screen for two Rheumatoid Factor (RF) biomarkers in the single test to provide a more comprehensive result.